After ConA injection, Gsdmd−/− mice exhibited more severe liver damage characterized by a lower survival rate, more extensive hepatocyte necrosis and apoptosis, and higher serum transaminase levels, indicating the protection of GSDMD in ConA-induced AIH. Here, GSDMD is linked to autoimmune hepatitis.